Back
GT Biopharma 10K Form
Sell
17
GTBP
GT Biopharma
Last Price:
3.30
Seasonality Move:
2.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTBP News And Ratings
See the #1 stock for the next 7 days that we like better than GTBP
GTBP Financial Statistics
Sales & Book Value
| Annual Sales: | $27K |
|---|---|
| Cash Flow: | $-2.05M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.41 |
| Price / Book: | 0.61 |
Profitability
| EPS (TTM): | -5.58360 |
|---|---|
| Net Income (TTM): | $-7.6M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
GT Biopharma Earnings Forecast
Key GT Biopharma Financial Ratios
- The Selling, General & Administrative Expenses for GTBP have been equal to 29,459.26% of Gross Profit Margin.
- The Interest Expense is -2.80% of Operating Income.
- Per Share Earnings over the last 40 years have been positive in 20 years.
GT Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GTBP |
| Website: | gtbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GTBP Technical Analysis vs Fundamental Analysis
Sell
17
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy or a Sell?
-
GT Biopharma stock is rated a Sell
The current GT Biopharma [GTBP] share price is $3.30. The Score for GTBP is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.